Stay updated on Dolutegravir Study in Completing IMPAACT Participants Clinical Trial

Sign up to get notified when there's something new on the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in the phase of a pediatric interventional study providing continued access to age-appropriate formulations of investigational product for eligible participants who previously participated in parent studies.
    Difference
    0.1%
    Check dated 2024-06-06T14:44:40.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed eligibility criteria for participants, including the requirement to have completed specific parent studies and demonstrated continued benefit from the investigational product. The new criteria also outline specific health conditions and prior treatments that must be met for inclusion in the study.
    Difference
    36%
    Check dated 2024-05-22T21:30:15.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:13:42.000Z thumbnail image

Stay in the know with updates to Dolutegravir Study in Completing IMPAACT Participants Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page.